Inventor
SORENSON MARGARET E
US18 patents
⚠️ This page may combine multiple inventors who share the name “SORENSON MARGARET E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS7176196B2Feb 13, 2007
Bicyclic heterocycles as HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO35 citations92
US7157447B2Jan 2, 2007
Bicyclic heterocycles as HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO30 citations92
US7115601B2Oct 3, 2006
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO35 citations92
US7037908B2May 2, 2006
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO37 citations92
US7109186B2Sep 19, 2006
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO27 citations91
US7135467B2Nov 14, 2006
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO34 citations90
US7511037B2Mar 31, 2009
N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor
BRISTOL MYERS SQUIBB CO7 citations73
US7902182B2Mar 8, 2011
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO4 citations63
US7897593B2Mar 1, 2011
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US7763630B2Jul 27, 2010
HIV integrase inhibitors
BRISTOL MYERS SQUIBB CO2 citations62
US7022667B2Apr 4, 2006
O-derivatized nocathiacin derivatives
BRISTOL MYERS SQUIBB CO5 citations62
US9273067B2Mar 1, 2016
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
BRISTOL MYERS SQUIBB CO2 citations61
US7491819B1Feb 17, 2009
N-[4-Fluorophenyl)methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor
BRISTOL MYERS SQUIBB CO5 citations57
US8629276B2Jan 14, 2014
Inhibitors of human immunodeficiency virus replication
BRISTOL MYERS SQUIBB CO1 citations51